Akums Drugs and Pharmaceuticals Q3 Results
- BSE: 544222
- NSE: AKUMS
- ISIN: INE09XN01023
- Sector: Biotechnology & Drugs
BSE
740.00
-15.20 (-2.01%)
-15.20 (-2.01%)Volume15.20 K
Updated: Tue 8 Sep, 2026 | 15:29:46
NSE
736.60-18.05 (-2.39%)
-18.05 (-2.39%)Volume1.99 L
Updated: Tue 8 Sep, 2026 | 15:31:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Akums Drugs and Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 23 | QoQ Comp | Dec 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,070.61 | 1,958.27 | 11.42% | 928.79 | 15.27% |
| Depreciation/ Amortization | 39.65 | 60.14 | 4.71% | 44.52 | -10.94% |
| Operating Income | 88.98 | 192.87 | 57.18% | 81.63 | 9.01% |
| Net Income | 66.32 | -,156.42 | 62.61% | 65.18 | 1.74% |
| Other Operating Expenses Total | 144.77 | 29.09 | 2.52% | 111.05 | 30.36% |
| Net Income Before Taxes | 99.57 | -71.67 | 51.61% | 91.05 | 9.35% |
| Total Revenue | 1,159.59 | 2,151.14 | 13.96% | 1,010.41 | 14.76% |
| Selling/ General/ Admin Expenses Total | 189.38 | 445.60 | 0.06% | 175.60 | 7.85% |
| Diluted Normalized EPS | 5.14 | -8.82 | 93.19% | 4.03 | 27.44% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.